Clinical Trial Update: Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 open-label study evaluating the safety of lacosamide as add-on therapy for primary generalized tonic-clonic seizures in people with epilepsy. Results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Vimpat (lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2012-09-07